These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22578688)

  • 1. Diagnostic utility of NT-proBNP and ANP in a canine model of chronic embolic pulmonary hypertension.
    Hori Y; Uchide T; Saitoh R; Thoei D; Uchida M; Yoshioka K; Chikazawa S; Hoshi F
    Vet J; 2012 Nov; 194(2):215-21. PubMed ID: 22578688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial injury-related changes in plasma NT-proBNP and ANP concentrations in a canine model of ischemic myocardial injury.
    Hori Y; Ohshima N; Chikazawa S; Kanai K; Hoshi F; Itoh N; Higuchi S
    Vet J; 2012 Jan; 191(1):46-51. PubMed ID: 21354834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute cardiac volume load-related changes in plasma atrial natriuretic peptide and N-terminal pro-B-type natriuretic peptide concentrations in healthy dogs.
    Hori Y; Sano N; Kanai K; Hoshi F; Itoh N; Higuchi S
    Vet J; 2010 Sep; 185(3):317-21. PubMed ID: 19709913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure.
    Kanno N; Hori Y; Hidaka Y; Chikazawa S; Kanai K; Hoshi F; Itoh N
    J Vet Med Sci; 2016 May; 78(4):535-42. PubMed ID: 26607133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison study on diagnostic and prognostic value of N-terminal pro-brain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Li YJ; Wang L; Chen KY; Chen YL; Cai JR; Zhou LJ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):544-7. PubMed ID: 16146600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension.
    Blyth KG; Groenning BA; Mark PB; Martin TN; Foster JE; Steedman T; Morton JJ; Dargie HJ; Peacock AJ
    Eur Respir J; 2007 Apr; 29(4):737-44. PubMed ID: 17135228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between glomerular filtration rate and plasma N-terminal pro B-type natriuretic peptide concentrations in dogs with chronic kidney disease.
    Miyagawa Y; Tominaga Y; Toda N; Takemura N
    Vet J; 2013 Aug; 197(2):445-50. PubMed ID: 23570775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NT-proBNP, NT-proANP and cTnI concentrations in dogs with pre-capillary pulmonary hypertension.
    Kellihan HB; Mackie BA; Stepien RL
    J Vet Cardiol; 2011 Sep; 13(3):171-82. PubMed ID: 21835711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Dong H; Chen DQ; Wang Y; Li M
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers.
    Allanore Y; Borderie D; Meune C; Cabanes L; Weber S; Ekindjian OG; Kahan A
    Arthritis Rheum; 2003 Dec; 48(12):3503-8. PubMed ID: 14674001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of NT-pro BNP and CT-ANP as markers of concentric hypertrophy in dogs with a model of compensated aortic stenosis.
    Hori Y; Tsubaki M; Katou A; Ono Y; Yonezawa T; Li X; Higuchi SI
    J Vet Intern Med; 2008; 22(5):1118-23. PubMed ID: 18681918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of N-terminal pro-brain natriuretic peptide for assessing hemodynamic significance of patent ductus arteriosus in dogs undergoing ductal repair.
    Hariu CD; Saunders AB; Gordon SG; Norby B; Miller MW
    J Vet Cardiol; 2013 Sep; 15(3):197-204. PubMed ID: 23933478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natriuretic peptides in patients with aortic stenosis.
    Qi W; Mathisen P; Kjekshus J; Simonsen S; Bjørnerheim R; Endresen K; Hall C
    Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma N-terminal pro-brain natriuretic peptide levels are positively correlated with pulmonary arterial pressure in atrial septal defect patients.
    Li ZF; Zhou DX; Wang QB; Pan WZ; Zhang L; Ge JB
    Regul Pept; 2013 May; 183():13-6. PubMed ID: 23499807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension.
    Mathai SC; Bueso M; Hummers LK; Boyce D; Lechtzin N; Le Pavec J; Campo A; Champion HC; Housten T; Forfia PR; Zaiman AL; Wigley FM; Girgis RE; Hassoun PM
    Eur Respir J; 2010 Jan; 35(1):95-104. PubMed ID: 19643943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease.
    Boswood A; Dukes-McEwan J; Loureiro J; James RA; Martin M; Stafford-Johnson M; Smith P; Little C; Attree S
    J Small Anim Pract; 2008 Jan; 49(1):26-32. PubMed ID: 18005104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of circulating amino terminal-pro-B-type natriuretic peptide concentration in dogs with respiratory distress attributable to congestive heart failure or primary pulmonary disease.
    Fine DM; DeClue AE; Reinero CR
    J Am Vet Med Assoc; 2008 Jun; 232(11):1674-9. PubMed ID: 18518809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated NT-proBNP levels or overt cardiac fibrosis but associated with increased levels of MR-proANP and MR-proADM: retrospective analysis of a French Canadian cohort.
    Miller L; Chartrand S; Koenig M; Goulet JR; Rich É; Chin AS; Chartrand-Lefebvre C; Abrahamowicz M; Senécal JL; Grodzicky T
    Scand J Rheumatol; 2014; 43(4):314-23. PubMed ID: 25089008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of plasma N-terminal pro-B-type natriuretic peptide concentrations in dogs with and without cardiac disease.
    Ettinger SJ; Farace G; Forney SD; Frye M; Beardow A
    J Am Vet Med Assoc; 2012 Jan; 240(2):171-80. PubMed ID: 22217025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal-pro-B type natriuretic peptide as a useful tool to evaluate pulmonary hypertension and cardiac function in CDH infants.
    Baptista MJ; Rocha G; Clemente F; Azevedo LF; Tibboel D; Leite-Moreira AF; Guimarães H; Areias JC; Correia-Pinto J
    Neonatology; 2008; 94(1):22-30. PubMed ID: 18160811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.